Willow Biosciences Inc (WLLW) — Cash Flow Reinvestment Rate

Latest as of March 2019: 2.89x

Willow Biosciences Inc (WLLW) has a Cash Flow Reinvestment Rate of 2.89x as of March 2019, reinvesting CA$29.33K (capex CA$14.67K plus investments CA$-14.67K) from operating cash flow of CA$10.14K. Explore WLLW capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.89x
(Capex + Investments) / Operating CF

Total Reinvested

CA$29.33K
Capex + Investments

Operating Cash Flow

CA$10.14K
CAD

Capital Expenditures

CA$14.67K
CAD

Willow Biosciences Inc Cash Flow Reinvestment Rate (2001–2001)

Historical reinvestment intensity for Willow Biosciences Inc across 1 annual periods. Also explore total assets of Willow Biosciences Inc for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Willow Biosciences Inc (2001–2001)

Year-by-year capital reinvestment analysis for Willow Biosciences Inc. For live market cap and broader valuation context, see Willow Biosciences Inc (WLLW) market capitalisation.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2001 0.00x CA$0.00 CA$281.00 CA$0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow